Sun Pharma gains on acquiring InSite Vision

03 Nov 2015 Evaluate

Sun Pharmaceutical Industries is currently trading at Rs. 875.25, up by 9.75 points or 1.13% from its previous closing of Rs. 865.50 on the BSE.

The scrip opened at Rs. 873.00 and has touched a high and low of Rs. 877.50 and Rs. 868.80 respectively. So far 34854 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1200.70 on 07-Apr-2015 and a 52 week low of Rs. 798.80 on 17-Dec-2014.

Last one week high and low of the scrip stood at Rs. 909.90 and Rs. 857.80 respectively. The current market cap of the company is Rs. 210680.20 crore.

The promoters holding in the company stood at 54.71% while Institutions and Non-Institutions held 35.62% and 9.68% respectively.

Sun Pharmaceutical Industries (Sun Pharma) has successfully completed acquistion of InSite Vision Incorporated (InSite). The acquisition was completed by means of a short-form merger under Delaware law. Post the short-form merger, InSite has become an indirect wholly owned subsidiary of Sun Pharma.

As a result of the merger, each issued and outstanding share of InSite common stock (other than shares of InSite common stock owned by the indirect wholly owned subsidiaries of Sun Pharma or InSite (or held in its treasury), any subsidiary of the indirect wholly owned subsidiaries of Sun Pharma or InSite, or by any stockholder of InSite who or which is entitled to and properly demands and perfects appraisal of such shares of InSite common stock pursuant to, and complies in all respects with, the applicable provisions of Delaware law) was converted into the right to receive US$0.35 and each option to acquire shares of InSite common stock that is unexercised and outstanding as of immediately prior to the merger, to the extent not then vested or exercisable, became fully vested and exercisable and was converted into the right to receive a cash payment in an amount equal to the excess, if any, of $0.35 over the exercise price of such option to acquire shares of InSite common stock. 

Sun Pharma is the fifth largest specialty generic pharmaceutical company in the world. The company provides high quality, affordable medicines trusted by healthcare professionals and patients in over 150 countries worldwide.


Sun Pharma Inds. Share Price

1669.20 -31.35 (-1.84%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×